Park Group of Hospitals declares Q1 FY''27 Unaudited Results

August 03, 2026 BSE Limited National Stock Exchange of India Limited P.J. Tower, Exchange Plaza, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 544645 SYMBOL: PARKHOSPS Subject: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)- Media Release Dear Sir/Madam, Pursuant to the provisions of Regulation 30 of the Listing Regulations, please find enclosed herewith the Earnings Release for the Financial Results for the quarter ended June 30, 2026. The disclosure will also be available on the Company's website at https://www.parkhospital.in/. This is for your information and records. Thanking you, For and on behalf of Park Medi World Limited Name: Abhishek Kapoor Designation: Company Secretary & Compliance Officer Encl: A/a Park Group of Hospitals declares Q1 FY’27 Unaudited Results Q1 FY’27 marks a strong start to the year, with year-on-year growth of 19% in Revenue, 20% in EBITDA and 35% in Net Profit. The Company expects to add 1,490 beds in calendar year 2026, c.46% growth in bed capacity over 2025 capacity of 3,250 beds, single largest addition of beds in any 12-month period. Gurugram, 3rd August 2026: Park Medi World Limited, North India’s 2nd largest hospital chain (“the Company”) (NSE: PARKHOSPS, BSE: 544645) today announced its unaudited financial results for the quarter ended 30th June 2026. Q1 FY’27 HIGHLIGHTS ➢ Quarterly Revenue of INR 4,757 mn, growth of 19% YoY ➢ Quarterly EBITDA of INR 1,261 mn, growth of 20% YoY, with EBITDA margin of 26.5%, expansion of 20 bps YoY ➢ Quarterly Net Profit of INR 886 mn, growth of 35% YoY, with Net Profit margin of 18.6%, expansion of 220 bps ➢ Negligible term bank debt of INR 256 mn as of 30th June 2026 ➢ Strong liquidity with INR 2,998 mn in Fixed Deposits. Growth Highlights ➢ Commissioned our largest-ever greenfield hospital in Panchkula (350 beds) on 10th April 2026. ➢ On 25th May 2026, the Company signed a definitive agreement to acquire ‘The Medicity Hospital’ in Rudrapur at a valuation of INR 177 crs. It is the Kumaon region’s largest NABH-accredited hospital. The hospital was commissioned on 2nd August 2026. ➢ On 30th June 2026, our wholly owned subsidiary, Umkal Health Care Private Limited, approved a significant expansion of its existing 225-bed Park Hospital in Palam Vihar, Gurugram, with the addition of 100 new beds under the name ‘Park Platinum’. The Palam Vihar facility is one of the flagship hospitals of the group; in FY’26, it had an occupancy of ~86% and delivered a revenue of ~INR 245 crs. The incremental capacity is expected to be commissioned in November 2026. It will take our consolidated Gurugram capacity to 750 beds. ➢ Today, on 3rd August 2026, the Company signed a definitive agreement to acquire ‘Mehar Hospital’ in Zirakpur at a valuation of INR 107 crs. ‘Mehar Hospital’ is a well-established multi-super speciality institution, with a capacity of 150+ beds, serving Zirakpur and the wider Tricity catchment. This acquisition will further strengthen our roadmap as the largest healthcare network in the Tricity region. The facility is expected to be commissioned in November 2026. ➢ Together with the already commissioned Agra facility with a capacity of 360 beds in February 2026 and the upcoming commissioning of our Febris multi-super-speciality hospital in Narela, Delhi with a capacity of 200 beds, the company expects to commission 1,490 beds in calendar year 2026, marking a capacity addition of c.46% in 2026 over the closing capacity of 3,250 beds in 2025. This is the single largest capacity addition by the company in any 12 month period. KEY CONSOLIDATED OPERATING & FINANCIAL SUMMARY: Particulars Q1 FY’27 Q1 FY’26 YoY% Q4 FY’26 QoQ% Operating Figures Total Bed Capacity 3,960 3,000 32% 3,610 10% Occupancy (%) 55.6% 67.8% -1,224 bps 62.5% -692 bps Total Patients ('000s) 249.8 213.9 17% 213.5 17% IPD patients ('000s) 26.3 22.8 16% 25.3 4% OPD patients ('000s) 223.4 191.2 17% 188.2 19% Financial Performance (INR mn) Revenue from Operations 4,757 3,988 19% 4,604 3% EBITDA (ex-Other Income) 1,261 1,049 20% 1,274 -1% EBITDA Margin (%) 26.5% 26.3% 20 bps 27.7% -116 bps Net Profit 886 655 35% 768 15% Net Profit Margin (%) 18.6% 16.4% 220 bps 16.7% 195 bps EPS (INR) 2.05 1.70 20% 1.78 15% Commenting on the overall performance of the Company, Dr. Ajit Gupta, Chairman, and Dr. Ankit Gupta, Managing Director, Park Medi World, said, “Q1 FY’27 has been a strong start to the year, with Revenue up 19%, EBITDA up 20% and Net Profit up 35% year-on-year, and Net Profit margin expanding 220 basis points to 18.6%. We have delivered this while executing the largest capacity expansion in our history, with newly commissioned beds still ramping up. With Panchkula, Rudrapur and today’s agreement to acquire Mehar Hospital in Zirakpur, we expect to commission 1,490 beds in calendar year 2026 — a c.46% addition to capacity, funded from a balance sheet carrying negligible term debt. Our near-term focus remains the integration of acquired assets, improving utilisation at newer facilities, and sustaining profitability while delivering affordable, high-quality healthcare and long-term value for all our stakeholders.” About Park Medi World Limited: Park Group of Hospitals is North India's 2nd largest hospital chain, currently operating 17 hospitals with a combined capacity of 4,290 beds as on date. The Group is in the process of integrating 5 additional hospitals and expanding capacity at 2 existing units. These are in various stages of execution and will add 1,450 beds to our network. With these, Park Group's total capacity is expected to reach 4,740 beds by March 2027 and 5,740 beds by March 2028, underscoring its commitment to leadership and growth in healthcare delivery. The Group has established a strong presence across 15 key cities including Delhi, Gurugram, Faridabad, Panipat, Karnal, Sonipat, Ambala, Mohali, Patiala, Bathinda, Behror, Jaipur, Agra, Panchkula and Rudrapur, and is expanding into Zirakpur (Punjab), Gorakhpur (Uttar Pradesh) and Rohtak (Haryana). Built on a founding commitment to accessible, high-quality healthcare, Park Group offers a comprehensive range of clinical services—spanning super-specialities such as cardiology, neurology, oncology, orthopaedics, gastroenterology, critical care, nephrology, organ transplants, gene therapy, stem-cell therapy, and women & child health. Each facility is equipped with modern medical infrastructure, advanced diagnostics, 24×7 emergency support, and multi-disciplinary teams delivering evidence-based care. Through continuous expansion and strategic investments, Park Group is strengthening its mission to build a dependable, technology-enabled healthcare ecosystem that serves both metropolitan and regional communities across North India. For more information visit www.parkhospital.in or contact: Adfactors Investor Relations Park Medi World Limited saloni.nagvekar@adfactorspr.com investor.relations@parkhospital.in mansi.pasari@adfactorspr.com Cautionary statement concerning forward-looking statements Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other risk factors, readers are cautioned not to place undue reliance on these forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.